Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia
Conditions: Sickle Cell Anemia in Children; Malaria Intervention: Drug: Dihydroartemisinin Piperaquine Sponsors: Liverpool School of Tropical Medicine; University of Bergen; University of Malawi; Makerere University; Indiana University; Global Health Uganda LTD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials